The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis
Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing
Roots Analysis is pleased to
announce the publication of its recent study, titled, “Continuous
Manufacturing Market (Small Molecules and Biologics), 2020 – 2030.”
The report features
an extensive study of the current market landscape and future opportunities for
companies with capabilities in continuous
manufacturing (both innovator companies with in-house expertise and
contract manufacturers). It features an in-depth analysis, highlighting the
capabilities of various stakeholders engaged in this domain. In addition to
other elements, the study includes:
§ A detailed assessment of the overall landscape
of companies with capabilities for continuous manufacturing
§
Elaborate profiles of
some of the key contract manufacturers active in the pharmaceutical and
biopharmaceutical continuous manufacturing market
§
An analysis of the
various partnerships related to continuous manufacturing, which have been
established since 2013
§
An analysis of the
expansions related to continuous manufacturing, which have been established
since 2013
§
An estimate of the
global, continuous manufacturing
capacity, based on the capacities of various industry stakeholders (as
available on their respective company websites).
§
A study of the
various grants that have been awarded to research institutes engaged in
projects related to continuous manufacturing, between 2014 and 2019
§
An in-depth analysis
of the various patents that have been filed / granted related to continuous
manufacturing till 2019
§ Initiatives taken by the leading pharmaceutical companies
(in terms of revenues), covering both partnered as well as in-house projects.
§ A review of the companies offering modular facilities /
modular cleanrooms
§ A case study of the companies offering technologies /
equipment
§ A case study on the roadmap for the adoption of continuous
manufacturing technique
§ A detailed market
forecast, featuring analysis of the current and projected future opportunity
across key market segments (listed below)
To request for Customize Report – https://www.rootsanalysis.com/reports/continuous-manufacturing/request-customization.html
§
Purpose of
Manufacturing
§
In-House
§
Contract service
§
Scale of Operation
§
Commercial
§
Preclinical /
Clinical
§
Type of Continuous
Manufacturing related Service
§
API Manufacturing
§
End Product
manufacturing
§
Type of Drug Molecule
§
Biologic
§
Small Molecule
§
Type of dosage form
§
Solid
§
Liquid
§
Key Geographical Regions
§
North America
§
Europe
§
Asia Pacific
To request for Sample
Report – https://www.rootsanalysis.com/reports/308/request-sample.html
§
Transcripts of interviews held with the following senior
level representatives of stakeholder companies
§
Andrea Adamo, Founder
and Chief Executive Officer, Zaiput Flow technologies
§
Bayan Takizawa, Co-Founder
and Chief Business Officer, CONTINUUS Pharmaceuticals
§
Nick Thomson, Senior
Director Chemical Research and Development, Pfizer
§
Himanshu Gadgil, Director
and Chief Scientific Officer, Enzene Biosciences
§
Eric Fang, Chief
Scientific Officer, Snapdragon Chemistry)
§
Ian Houson, Technical
Project Manager, Continuous Manufacturing and Crystallization, University of
Strathclyde
Key companies covered in the report
§
AbbVie Contract
Manufacturing
§
Ajinomoto Bio-Pharma
Services
§
Almac
§
Boehringer Ingelheim
BioXcellence
§
Cambrex
§
CordonPharma
§
Hovione
§
Kaneka
§
Lonza
§
Patheon
§
SK biotek
§
WuXi AppTec
For more information please
click on the following link:
https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html
Other Offerings
1.
Pharmaceutical
Contract Manufacturing Market (2nd Edition), 2018-2028
2.
Biopharma Contract Manufacturing Market (3rd Edition), 2019
- 2030
3.
China Pharmaceutical Contract Manufacturing Services Market,
2020-2030
4.
China Biopharmaceutical Contract Manufacturing Market, 2020
- 2030
About Roots Analysis
Roots Analysis is one of the fastest
growing market research companies, sharing fresh and independent perspectives
in the bio-pharmaceutical industry. The in-depth research, analysis and
insights are driven by an experienced leadership team which has gained many
years of significant experience in this sector. If you’d like help with your
growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private
Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Comments
Post a Comment